These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28254531)

  • 1. Oleoylethanolamide: A fat ally in the fight against obesity.
    Brown JD; Karimian Azari E; Ayala JE
    Physiol Behav; 2017 Jul; 176():50-58. PubMed ID: 28254531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review.
    Laleh P; Yaser K; Alireza O
    J Cell Physiol; 2019 Jun; 234(6):7893-7902. PubMed ID: 30537148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
    Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.
    Igarashi M; Narayanaswami V; Kimonis V; Galassetti PM; Oveisi F; Jung KM; Piomelli D
    Pharmacol Res; 2017 Mar; 117():75-81. PubMed ID: 28007570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice.
    Caillon A; Duszka K; Wahli W; Rohner-Jeanrenaud F; Altirriba J
    Metabolism; 2018 Oct; 87():13-17. PubMed ID: 29936173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
    Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
    Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleic acid-derived oleoylethanolamide: A nutritional science perspective.
    Bowen KJ; Kris-Etherton PM; Shearer GC; West SG; Reddivari L; Jones PJH
    Prog Lipid Res; 2017 Jul; 67():1-15. PubMed ID: 28389247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain molecules and appetite: the case of oleoylethanolamide.
    Sarro-Ramírez A; Sánchez-López D; Tejeda-Padrón A; Frías C; Zaldívar-Rae J; Murillo-Rodríguez E
    Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):88-91. PubMed ID: 23464987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid.
    Igarashi M; Iwasa K; Yoshikawa K
    Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102228. PubMed ID: 33385936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
    Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
    Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lipid messenger OEA links dietary fat intake to satiety.
    Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
    Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oleoylethanolamide as a feeding regulator in goldfish.
    Tinoco AB; Armirotti A; Isorna E; Delgado MJ; Piomelli D; de Pedro N
    J Exp Biol; 2014 Aug; 217(Pt 15):2761-9. PubMed ID: 24855680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.
    Igarashi M; DiPatrizio NV; Narayanaswami V; Piomelli D
    Biochim Biophys Acta; 2015 Sep; 1851(9):1218-26. PubMed ID: 26024927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.
    Li L; Li L; Chen L; Lin X; Xu Y; Ren J; Fu J; Qiu Y
    J Pharmacol Sci; 2015 Mar; 127(3):244-50. PubMed ID: 25837920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.